Fieldpoint Private Securities’s PetMed Express PETS Stock Holding History

Fieldpoint Private Securities’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-600	Closed	-$16K	–	406
2018 Q3	$20K	Hold	600	–	–	0.01%	356
2018 Q2	$26K	Hold	600	–	–	0.01%	342
2018 Q1	$25K	Hold	600	–	–	0.01%	339
2017 Q4	$27K	Buy	+600	New	+$23.6K	0.01%	325

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.82B AUM 7.52% 1-Year Est. Return

Fieldpoint Private Securities's PETS Position: Q4 2018 in Review

Fieldpoint Private Securities sold out of PetMed Express (PETS) in Q4 2018, closing a stake of 600 shares — an estimated $16K sold.

Fieldpoint Private Securities first reported a position in PETS in Q4 2017 and held it in 4 quarters. The position peaked at $27K in Q4 2017. 200 funds tracked by Wall St. Rank hold PETS as of Q4 2018.

Fieldpoint Private Securities reported no remaining PetMed Express position as of Q4 2018 after selling out during the quarter.
Fieldpoint Private Securities sold 600 PetMed Express shares in Q4 2018, an estimated $16K.
Fieldpoint Private Securities first reported a position in PetMed Express in Q4 2017 and held it in 4 quarters.
Fieldpoint Private Securities's PetMed Express position peaked at $27K in Q4 2017.
200 funds tracked by Wall St. Rank held PetMed Express as of Q4 2018.

Based on Fieldpoint Private Securities's 13F filing for Q4 2018, filed 11 Feb 2019.